TKT and glioblastoma: Survival analysis revealed that TMZ treatment extended the survival of tumor-bearing mice in both DesPro and DesPro-TK xenografts, but the combination of TMZ and GCV in pericytelow GBM xenografts did not prolong the survival of mice bearing DesPro-TK xenografts (Supplementary information, Fig. S2c).